Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/7/2019
Top Execs from AstraZeneca, Roche, Sanofi and GSK Tout China Investmen...
11/7/2019
Sun Pharma, AstraZeneca Enter Licensing Deal to Market Novel Oncology ...
11/7/2019
MD Anderson Inks In-licensing Deal with Artios and ShangPharma
11/7/2019
NMPA Approves Bio-Thera’s Adalimumab Biosimilar
11/6/2019
Jacobson Pharma to Market Vemedia's Excilor Portfolio in China
11/4/2019
NMPA Approves the World's First Seaweed-based Alzheimer's Drug
11/1/2019
China Issues Opinions for Establishing / Improving Senior Healthcare S...
11/1/2019
NMPA and WHO Sign Statement of Intent to Deepen Cooperation
11/1/2019
Amgen To Acquire 20.5% Stake In BeiGene to Expand Anticancer Sales in ...
10/31/2019
Financial-related Company News in Brief
10/31/2019
Listed Chinese MedPharm Cos Report Varied Performance in 3Qs/2019
10/31/2019
Recent Executive Moves
10/31/2019
SinoMab BioScience Files $223M IPO in Hong Kong
10/31/2019
Alphamab Seeks Approval for HK IPO of Upto $350M - Sources
10/31/2019
Shanghai's I-Mab Plans $100M Nasdaq IPO
10/31/2019
U.S. Mulls Boost of Domestic Pharma Production as Quality and China De...
10/30/2019
Amgen Submits NDA for Blincyto in China
10/30/2019
In Generic Drug Plants in China and India, Data Falsification Is Still...
10/30/2019
Pfizer and Merck Reports Strong China Growth in Q3
10/29/2019
39 Listed Pharma Cos Report Performance Results in 3Qs/2019
10/29/2019
China Introduces New Policy for Promotion of Traditional Chinese Medic...
10/28/2019
Menarini to Market Tillotts's IBD Drug Asacol in China
10/28/2019
AZ Sees 30% China Sales Surge in 3Qs/2019, Warning Slower Growth Forwa...
10/28/2019
WuXi STA's Jinshan Facility Passes EMA Inspection
10/25/2019
SMEI: Chinese County Level Public Hospital Drug Sales Up 7.8% in 2018
10/25/2019
SMEI: Chinese Township Health Center Drug Sales Up 9.3% in 2018
10/25/2019
SMEI: Chinese Offline Retail Pharmacy Drug Sales Up 6.8% in 2018
10/25/2019
SMEI: Chinese Online Pharmacy Drug Sales Up 41.4% in 2018
10/25/2019
SMEI: Drug Spending Accounted for 34% of Chinese Healthcare Expenditur...
10/25/2019
CPA: Chinese Hospital Drug Monitor Report 2018
Page:
106
/
334
Total number of articles:
9993
:
[First]
[<<]
[104]
[105]
[106]
[107]
[108]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit